Clinical Research Professional Certification Preparation And Good Clinical Practice (GCP) Review

This set of flashcards covers key concepts and vocabulary related to clinical research practices, Good Clinical Practice (GCP), regulations, and ethical considerations.

Clinical Research Professional

A professional certified in clinical research, recognized for knowledge and competency in conducting clinical trials.

Good Clinical Practice (GCP)

An international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve human subjects.

CCRP® Certification

Certified Clinical Research Professional certification indicating the holder has met necessary educational and experiential standards.

SOCRA

The Society of Clinical Research Associates, an organization promoting clinical research excellence.

Disclosure of Relationships

Transparency regarding potential conflicts of interest in clinical research.

Commercial Relationships

Financial or business ties between researchers and commercial entities that may influence study outcomes.

Investigator's Responsibilities

Duties of a clinical trial investigator, including participant welfare and adherence to protocols.

Informed Consent

A process ensuring participants understand the nature and risks of a study before agreeing to participate.

Institutional Review Board (IRB)

A committee that reviews and approves research studies to ensure the ethical treatment of participants.

Adverse Event (AE)

Any undesirable experience associated with the use of a medical product in a patient.

Serious Adverse Event (SAE)

An adverse event that results in significant medical events, including death or hospitalization.

Nuremberg Code

A set of research ethics principles for human experimentation established after WWII.

Belmont Report

A report outlining ethical principles and guidelines for research involving human subjects.

Declaration of Helsinki

An international ethical guideline for medical research involving human subjects.

Investigational New Drug (IND)

An application required by the FDA to begin human clinical trials for a new drug.

New Drug Application (NDA)

A formal proposal submitted to the FDA for the approval of a new pharmaceutical for sale.

Electronic Records

Digital documentation of patient data or study information, subject to specific regulations.

Device Application

The process to submit a medical device for regulatory approval to the FDA.

Safety Reporting

A requirement to report adverse events to ensure participant safety throughout a study.

Financial Disclosure Forms

Documents that require investigators to disclose any financial interest or arrangement with the study sponsor.

GCP Guidelines

Standards to ensure clinical trials are conducted ethically and scientifically.

Regulatory Binder

A compilation of essential documents necessary for conducting a clinical trial.

Investigator's Brochure

A document that provides the investigator with the necessary information about an investigational product.

Research Regulations

Laws and guidelines governing the conduct of research involving human subjects.

Ethical Foundations of Research

The moral principles guiding the conduct of research to ensure participant welfare.

Clinical Trial Phases

Stages of drug development: Phase I (safety), Phase II (efficacy), Phase III (confirmation of effectiveness), Phase IV (post-marketing studies).

Informed Consent Process

The procedure of obtaining voluntary consent from participants with full understanding of the study.

Randomization

The process of randomly assigning participants to treatment or control groups in a clinical trial.

Blinding

A method used in clinical trials to prevent bias by concealing the treatment assignments.

Audit

A systematic review and evaluation of a study's adherence to its protocol and regulations.

Regulatory Submission

The process of submitting required documentation to authorities for approval.

Clinical Protocol

A document detailing the plan for a clinical trial, including objectives, design, and methodology.

Essential Documents

Documents required to demonstrate compliance with Good Clinical Practice throughout the clinical trial.

Clinical Trial Monitoring

The oversight of a clinical trial to ensure compliance with regulatory requirements and study protocols.

Eligibility Criteria

Predefined standards that participants must meet to be included in a clinical trial.

Investigational Product (IP)

A pharmaceutical or device being tested in a clinical trial.

Continuing Review

Ongoing evaluation of a research study by an IRB, typically done at least annually.

Rescue Therapy

Treatment provided to participants who experience an adverse event during a study.

Research Misconduct

Actions that violate ethical standards in conducting or reporting research.

Quality Control

Measures taken to ensure that the results of a clinical trial are reliable and accurate.

Good Manufacturing Practice (GMP)

Regulations for the manufacturing of drugs ensuring quality and safety.

Clinical Data Management

The process of collecting and managing clinical trial data.

Case Report Form (CRF)

A paper or electronic document used to record data for each participant in a clinical trial.

Protocol Amendment

A change to a study protocol after initial approval.

Site Evaluation

Assessment of a potential clinical trial site for its suitability to conduct a study.

Monitoring Visit

Periodic site visits by a clinical research associate to review study compliance.

Principal Investigator (PI)

The lead researcher responsible for the conduct of a clinical trial.

Contract Research Organization (CRO)

A service organization that provides support for the pharmaceutical, biotechnology, and medical device industries.

Withdrawal of Consent

The decision by a participant to discontinue their involvement in a study.

Ethics Committee

A group that reviews and monitors research involving human participants to ensure compliance with ethical standards.

Patient Recruitment

The process of enrolling participants in a clinical trial.

Audit Trail

A record that traces the details of any events or transactions relevant to the data in a clinical trial.

Phase IV Trials

Studies conducted after a product has been approved to gain additional information on the drug’s risks, benefits, and optimal use.

Compassionate Use

Access to investigational drugs outside of clinical trials for patients with serious or life-threatening conditions.

Post-Market Surveillance

Monitoring of a product after it has been approved and is on the market.

Systematic Review

A comprehensive review of research studies to assess the state of evidence on a particular topic.

Regulatory Compliance

Adherence to laws, regulations, guidelines, and specifications relevant to an organization.

Patient Consent Form

The document that outlines the details of a clinical trial and the rights of participants, which must be signed to indicate consent.

Eligibility Screening

The process of determining if potential candidates are qualified to participate in a clinical trial.

CFR (Code of Federal Regulations)

The codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the federal government.

FDA (Food and Drug Administration)

The regulatory agency that oversees the safety and efficacy of drugs, medical devices, and food products in the United States.

Ethics Approval

The process of obtaining permission to conduct a study from a relevant ethics board or IRB.

Clinical Trials Registration

The process of submitting trial information to a public database prior to the start of a clinical trial.

Pharmacovigilance

The science of monitoring the safety of drugs and taking action to reduce risk and increase patient safety.

Quality Assurance

The systematic process ensuring that quality requirements for products and services are fulfilled.

Research Ethics

The ethical principles that govern the conduct of research, particularly with human subjects.

Clinical Research Associate (CRA)

A person who monitors and oversees the clinical trial site for compliance with the study protocol and regulatory requirements.

Randomized Control Trial (RCT)

A study design in which participants are randomly assigned to receive either the intervention or the control.

Drug Development

The process of bringing a new pharmaceutical drug to the market after successful research and clinical trials.

Safety Monitoring Board

An independent group that reviews data from clinical trials to ensure participant safety.

Goals of GCP

To ensure that the rights, safety, and well-being of trial subjects are protected.

Regulatory Authority

Government agency responsible for overseeing the implementation of laws and regulations related to public health and safety.

Participant Confidentiality

The ethical obligation to protect the identity and personal information of participants in research.

Qualitative Research

Research that seeks to understand human behavior and the reasons that govern such behavior.

Quantitative Research

Research involving the systematic empirical investigation of observable phenomena via statistical, mathematical, or computational techniques.

Protocol Compliance

Adherence to the study protocol as designed and approved by the IRB.

Expanded Access Protocol

A method allowing patients to gain access to investigational treatments outside of clinical trials under certain conditions.

Direct-to-Consumer Advertising

Advertising aimed directly at patients rather than healthcare professionals, often pertaining to pharmaceuticals.

Research Funding

Financial support necessary to carry out clinical trials, may come from various sources including government and industry.

SOP (Standard Operating Procedure)

Documented procedures used in conducting clinical trials to ensure consistent performance.

Monitoring Plan

A plan outlining how the monitoring of a trial will be conducted, including frequency and methodology.

Clinical Study Report

A comprehensive report that summarizes the key findings and methodology of a clinical trial.

Risk-Based Monitoring

An approach to clinical trial oversight that focuses on identifying and mitigating risks to data quality and participant safety.

Regulatory Authority Oversight

The process by which regulatory bodies review and regulate clinical trials to ensure compliance.

Vulnerable Populations

Groups who may need special protection in research settings due to their increased vulnerability.

Research Protocol

A detailed plan for a research study, outlining objectives, methodology, statistical considerations, and organization.

Pharmaceutical Innovation

The process of developing new and improved medications to enhance healthcare outcomes.

De Novo Classification

A regulatory pathway for low- to moderate-risk devices without a predicate.

510(k) Submission

A request for the FDA to determine whether a medical device is substantially equivalent to an existing one.

Biologics License Application (BLA)

The application submitted to the FDA for the approval of biological products.

Environmental Impact Assessment

A process to evaluate the potential environmental impacts of proposed projects, including drug manufacturing.

Clinical Research Ethics Committee

A committee that reviews the ethical implications of proposed research projects.

Trial Master File (TMF)

The collection of essential documents needed to manage a clinical trial.

Audit Trail Documentation

Records that trace the detailed history of data and modifications in clinical research.

Efficacy and Safety Studies

Investigations designed to determine the effectiveness and safety of a drug.

Research Integrity

Adherence to ethical and scientific standards in conducting and reporting research.

Pharmaceutical Regulations

Laws and guidelines governing the manufacturing, distribution, and use of pharmaceuticals.

Clinical Trial Phases I-III

Stages of clinical trials focusing on safety, efficacy, and comparative effectiveness of drugs.

Randomized Trials

Studies that allocate participants to different groups through random selection.

Therapeutic Misconception

When research participants mistakenly believe that the purpose of a clinical trial is to benefit them directly.